EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Practical Considerations Concerning Preeclampsia Subgroups

Peter Tamas, Balint Farkas iD, Jozsef Betlehem

Journal of Clinical Medicine · 06.04.2025 · 14 (7) · 2498

DOI: 10.3390/jcm14072498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.04.2025. Verfasst von Peter Tamas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Health Sciences, University of Pécs, H-7624 Pécs, Hungary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia is one of the most serious clinical syndromes which can occur during pregnancy. According to our current knowledge, preeclampsia cannot be cured. However, a significant step forward is the recognizing preeclampsia is not a homogenous syndrome, i.e., different pathological events can lead to the hypertension + symptoms of organ damage, occurring in the second half of pregnancy. Clinically, two kinds of preeclampsia can be distinguished. The “classic” placental preeclampsia of immunological origin is characterized by contracted blood volume, fetal growth restriction, and marked alterations in laboratory indices. Patients in this subtype are characteristically young and primiparous. Clinical symptoms appear during the late second or early third trimester and show a quick progression. The outcome in cases of placental preeclampsia is frequently serious. For preventing the most critical conditions, the necessary delivery induction usually results in a preterm newborn. The maternal preeclampsia is associated with high blood volume. The characteristic augmented gestational weight gain is mostly a condition with a multifactorial background; however, obesity seems a critical risk factor. The early clinical symptoms are leg, and then generalized edema; hypertension and proteinuria appear after that. Laboratory abnormalities are rare; even platelet count remains within the normal range. The outcome is usually favorable; however, serious organ edema can lead to eclampsia or placental detachment. In the case of both types—from the name to the therapy—new data worthy of consideration have been created, which also justifies a change in attitude.

Schlagwörter

Stichwörter der Autor:innen

clinical considerationsmaternal preeclampsiaplacental preeclampsia

Autor:innen und Institutionen

  • Doctoral School of Health Sciences, University of Pécs, H-7624 Pécs, Hungary.
  • Department of Obstetrics and Gynecology, School of Medicine, University of Pécs, H-7624 Pécs, Hungary.

ORCID-Profile: Balint Farkas

Zitieren

APA

Tamas, P., Farkas, B., & Betlehem, J. (2025). Practical Considerations Concerning Preeclampsia Subgroups. Journal of Clinical Medicine, 14(7), 2498. https://doi.org/10.3390/jcm14072498

Vancouver

Tamas P, Farkas B, Betlehem J. Practical Considerations Concerning Preeclampsia Subgroups. Journal of Clinical Medicine. 2025;14(7):2498. doi:10.3390/jcm14072498

BibTeX
@article{Tamas2025,
  author = {Tamas, Peter and Farkas, Balint and Betlehem, Jozsef},
  title = {Practical Considerations Concerning Preeclampsia Subgroups},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {2498},
  doi = {10.3390/jcm14072498}
}
Kostenlos starten →